Survival outcomes in patients with de novo metastatic Merkel cell carcinoma according to site of metastases
In this cohort of patients with <i>de novo</i> metastatic MCC, the presence of bone metastases, but not the number of organs involved, was associated with significantly worse OS. The presence of lymph node metastases was associated with lower MCC-specific death. Further research is warranted in larger cohorts to investigate the impact of the location of metastases on clinical outcomes.
Authors
- Manisha Thakuria (ORCID: https://orcid.org/0000-0002-9024-9090)
- Furkan Bahar (ORCID: https://orcid.org/0000-0002-4672-5977)
- Emily Kim (ORCID: https://orcid.org/0000-0001-6427-7234)
- Ann W. Silk (ORCID: https://orcid.org/0000-0003-3877-3984)
- Mofei Liu (ORCID: https://orcid.org/0000-0002-6861-5998)
- Anita Giobbie‐Hurder (ORCID: https://orcid.org/0000-0003-2496-7737)
- Karam Khaddour (ORCID: https://orcid.org/0000-0001-6697-3516)
- Matheus Lobo
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- AC Camargo Hospital (BR)
- Dana-Farber Cancer Institute (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-16
- DOI
- https://doi.org/10.3389/fonc.2024.1444590
- Citations
- 3
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.85